Subsidiaries With Material Non-controlling Interest - Summarized Income Statement (Details) - EUR (€) € in Thousands |
12 Months Ended | ||
|---|---|---|---|
Dec. 31, 2022 |
Dec. 31, 2021 |
Dec. 31, 2020 |
|
| Net Sales | € 983,680 | € 843,920 | € 662,037 |
| Cost of Sales | 663,879 | 578,515 | 467,861 |
| Gross Profit | 319,801 | 265,405 | 194,176 |
| Other operating income | 18,850 | 9,386 | 5,230 |
| Selling and marketing expenses | 26,086 | 20,448 | 20,044 |
| Research and development expenses | 34,387 | 29,616 | 17,390 |
| General and administrative expenses | 85,747 | 62,502 | 58,863 |
| Operating Profit | 192,431 | 162,225 | 103,109 |
| Interest income | 25,050 | 21,709 | 14,926 |
| Interest expense | 29,840 | 18,808 | 21,848 |
| Profit Before Tax | 187,641 | 165,673 | 96,279 |
| Income taxes | 44,625 | 31,404 | 17,682 |
| Net Profit | 143,016 | 134,269 | 78,597 |
| Total comprehensive income | 157,253 | 148,510 | 55,307 |
| Attributable to non-controlling interests | 167 | (52) | 84 |
| Ompi of Japan Co., Ltd. | |||
| Net Sales | 7,059 | 4,325 | 6,811 |
| Cost of Sales | 5,779 | 3,542 | 5,509 |
| Gross Profit | 1,280 | 783 | 1,302 |
| Selling and marketing expenses | 484 | 299 | 349 |
| Research and development expenses | 144 | 150 | 157 |
| General and administrative expenses | 126 | 452 | 518 |
| Operating Profit | 526 | (118) | 278 |
| Interest income | 33 | 37 | 17 |
| Interest expense | 45 | 90 | 74 |
| Profit Before Tax | 514 | (171) | 221 |
| Income taxes | 154 | (48) | 66 |
| Net Profit | 360 | (123) | 155 |
| Total comprehensive income | 388 | (123) | 155 |
| Attributable to non-controlling interests | 176 | (60) | 76 |
| Medical Glass a.s. | |||
| Net Sales | 38,362 | 41,643 | 36,852 |
| Cost of Sales | 37,255 | 34,425 | 30,039 |
| Gross Profit | 1,107 | 7,218 | 6,813 |
| Other operating income | 42 | 195 | 43 |
| Selling and marketing expenses | 46 | 177 | 165 |
| General and administrative expenses | 4,470 | 3,302 | 2,715 |
| Operating Profit | (3,367) | 3,934 | 3,976 |
| Interest income | 47 | 111 | 2 |
| Interest expense | 136 | 42 | 30 |
| Profit Before Tax | (3,456) | 4,003 | 3,948 |
| Income taxes | 79 | 826 | 834 |
| Net Profit | (3,535) | 3,177 | 3,114 |
| Total comprehensive income | (3,535) | 3,165 | 3,111 |
| Attributable to non-controlling interests | € (9) | € 8 | € 8 |
| X | ||||||||||
- Definition The amount of change in equity resulting from transactions and other events, other than those changes resulting from transactions with owners in their capacity as owners. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of all expenses directly or indirectly attributed to the goods or services sold. Attributed expenses include, but are not limited to, costs previously included in the measurement of inventory that has now been sold, such as depreciation and maintenance of factory buildings and equipment used in the production process, unallocated production overheads, and abnormal amounts of production costs of inventories. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of costs associated with financing activities of the entity. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of income associated with interest and other financing activities of the entity. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The amount of expense relating to general and administrative activities of the entity. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The amount of revenue less cost of sales. [Refer: Cost of sales; Revenue] Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The aggregate amount included in the determination of profit (loss) for the period in respect of current tax and deferred tax. [Refer: Current tax expense (income); Deferred tax expense (income)] Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of operating income (expense) that the entity does not separately disclose in the same statement or note. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income] Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The profit (loss) from continuing and discontinued operations attributable to non-controlling interests. [Refer: Profit (loss); Non-controlling interests] Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The profit (loss) before tax expense or income. [Refer: Profit (loss)] Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The profit (loss) from operating activities of the entity. [Refer: Profit (loss)] Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The amount of expenditure directly attributable to research or development activities, recognised in profit or loss. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The income arising in the course of an entity's ordinary activities. Income is increases in assets, or decreases in liabilities, that result in increases in equity, other than those relating to contributions from holders of equity claims. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of expense relating to the marketing and selling of goods or services. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|